REPARIL GEL 40G 1%+5%

REPARIL GEL

active ingredients

REPARIL 1% + 5% gel 100 g gel contains: Active ingredients: Extract 1 g Salicylate diethylene 5 g REPARIL 2% + 5% gel 100 g gel contains: Active ingredients: Extract 2 g Salicylate 5 g Excipients with known effects Lavender oil and bitter orange flowers oil with d-limonene, make solo and linalol. For the full list of excipients see, paragraph 6.1

Excellent

Lavender essence, bitter orange flower essence, carbomeres, macrogol 6 glycerol caprilocaprate, disodium edetate, tromethamol, isopropyl alcohol, purified water.

Therapeutic indications

Minor traumatology

Contraindications

Hypersensitivity to active ingredients or any of the excipients. REPARIL should not be used on open injuries (low), mucous membranes and skin areas treated with radiation.

Population

Adults and teenagers (12-18 years): Apply and spread a thin layer of REPARIL on the skin of the area to be treated from 1 to 3 times a day. Apply the gel directly to the affected part. After each application wash your hands thoroughly. Children under 12 years: Security and effectiveness of REPARIL children under 12 years of age have not been established. There are no available data.

Conservation

This medicine does not require any special condition of conservation

Warnings

There is no risk of addiction and addiction. As a preparation for topical applications, its use must be exclusively external. Prolonged use of topical products can give rise to awareness-raising phenomena. This medicine contains, as fragrances, lavender oil and bitter orange blossom oil with d-limonene, make alone and linalol. These substances can cause allergic reactions.

Interactions

No interactions with other medicines have been reported.

Effects

In rare cases hypersensitivity reactions such as redness, dequamation and dehydration of the skin may appear. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions occurring after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Overdosing

No overdose cases have been reported.

In case of pregnancy and during breastfeeding we do not recommend using REPARIL if not under strict medical control. However, prolonged use (maximum 3 weeks) of the product should be avoided on extended skin areas during pregnancy and breast use during breastfeeding.

Source: Farmadati